Path: utzoo!utgpu!watmath!uunet!bionet!nihcu.bitnet!CZJ From: CZJ@nihcu.bitnet Newsgroups: bionet.sci-resources Subject: (none) Message-ID: <8901161440.AA01326@net.bio.net> Date: 16 Jan 89 14:00:39 GMT Sender: daemon@NET.BIO.NET Lines: 204 Attached is the Table of Contents and Items of Interest from the NIH Guide to Grants and Contracts, Jan 13, 1989. Jim Cassatt. -------------------------------------------------------------------- Vol. 18, No. 1, January 13, 1989 NOTICES REMINDER: LETTERS OF REFERENCE ...........................(84/111)......... 1 Division of Research Grants Index: RESEARCH GRANTS WORKSHOP-ETHICAL ISSUES IN SENSITIVE BEHAVIORAL RESEARCH INVOLVING MINORS .. 1 National Institutes of Health (114/143) Index: NATIONAL INSTITUTES OF HEALTH NOTICE OF AVAILABILITY - RECOMMENDED COUNCIL GUIDELINES ON ETHYL ALCOHOL ADMINISTRATION IN HUMAN EXPERIMENTATION ...........(146/174)........ 1 National Institute on Alcohol Abuse and Alcoholism Index: ALCOHOL ABUSE, ALCOHOLISM NOTICE OF MEETING .........................................(177/229)........ 2 National Institutes of Health Index: NATIONAL INSTITUTES OF HEALTH NOTICE OF MEETING .........................................(241/301)........ 3 Public Responsibility in Medicine and Research Index: PUBLIC RESPONSIBILITY IN MEDICINE AND RESEARCH REQUIREMENTS FOR DRUG-FREE WORKPLACE: GRANT AND CONTRACT AWARDEES ......... 3 Public Health Service (304/355) Index: PUBLIC HEALTH SERVICE EXPANDED AUTHORITIES FOR GRANTEE ORGANIZATIONS -- CLARIFICATION OF APPLICABILITY TO CERTAIN GRANT AWARD MECHANISMS ........(358/392)........ 4 National Institutes of Health Index: NATIONAL INSTITUTES OF HEALTH DATED ANNOUNCEMENTS (RFPs AND RFAs) LIVER TISSUE PROCUREMENT AND DISTRIBUTION SYSTEM (LTPADS) (RFP) (404/446)... 5 National Institute of Diabetes, and Digestive and Kidney Diseases Index: DIABETES, DIGESTIVE AND KIDNEY DISEASES EVALUATION OF PHYSICIAN ATTITUDES AND PRACTICE REGARDING CHOLESTEROL AND CORONARY HEART DISEASE (CHD) (RFP) .........(449/499)....... 5 National Heart, Lung, and Blood Institute Index: HEART, LUNG, AND BLOOD PHASE II-B RANDOMIZED CONTROLLED STUDY OF TISSUE PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE - CLINICAL CENTER ......(502/550)....... 6 National Institute of Neurological Disorders and Stroke Index: NEUROLOGICAL DISORDERS, STROKE THE RELATIONSHIP BETWEEN BLOOD AND TISSUE MICRONUTRIENT LEVELS IN HUMANS ... 7 National Cancer Institute (561/653, 1622/1914) Index: CANCER NEW TECHNIQUES SMALL GRANTS FOR ALCOHOL RESEARCHERS (RFA) ...(656/748)...... 8 National Institute on Alcohol Abuse and Alcoholism (656/748, 1204/1618) Index: ALCOHOL ABUSE, ALCOHOLISM DRUG DEVELOPMENT--MEDICINAL CHEMISTRY CONSIDERATIONS (RFA) ...(751/815)..... 9 National Institute on Drug Abuse Index: DRUG ABUSE ONGOING PROGRAM ANNOUNCEMENTS RESEARCH ON MENTAL HEALTH SERVICES FOR CHILDREN AND ADOLESCENTS (821/854)...10 National Institute of Mental Health Index: MENTAL HEALTH RESEARCH RELATED TO NURSING CARE OF PERSONS WITH HIV ........(857/986)......10 National Center for Nursing Research Index: NURSING RESEARCH NATIONAL RESEARCH SERVICE AWARD INSTITUTIONAL TRAINING GRANTS (T32) ........12 National Center for Nursing Research (989/1084) Index: NURSING RESEARCH RESEARCH AND RESEARCH DEMONSTRATIONS ON HOMELESS SEVERELY MENTALLY ILL ADULTS AND HOMELESS FAMILIES WITH CHILDREN WHO ARE AT RISK OF SEVERE EMOTIONAL DISTURBANCE .....................(1087/1144)....13 National Institute of Mental Health Index: MENTAL HEALTH NOTICES REMINDER: LETTERS OF REFERENCE P.T. 22, 34; K.W. 1014002, 1014006 Division of Research Grants Previous announcements in the NIH Guide for Grants and Contracts have instructed applicants for the Research Career Development Award (RCDA), the First Independent Research Support and Transition (FIRST) Award, and individual and senior National Research Service Award (NRSA) Fellowships to submit letters of reference with their application. The NIH is now reminding applicants submitting REVISED applications for RCDA, FIRST, and NRSA fellowships that they must again submit letters of reference. Otherwise their applications will be returned without review. For RCDA applications, both new and revised, reference guidelines to be sent to referees are included in the PHS 398 kit (revised 9/86). For NRSA fellowship applications, new and revised, the reference form (PHS 416-3) is included in the PHS 416-1 kit (revised 6/85). For FIRST Award applications, new and revised, there are no special reference forms or printed guidelines to be sent to the referees. Applicants should contact their referees well in advance of the application submission date, advising referees to return the letters of reference to the applicant in sealed envelopes as soon as possible. To protect the utility and confidentiality of reference letters, applicants are asked not to open the sealed envelopes. The sealed envelopes MUST be attached to the front of the original applications. NOTICE OF MEETING P.T. 42, FF; K.W. 0710030, 0720005 National Institutes of Health Notice is hereby given that the National Institutes of Health (NIH) will hold the first two of a series of five regional public meetings to be conducted under the auspices of the Office of the Director, NIH, on "Programs for Support of Minorities in Biomedical Research." The purpose of the meetings is two-fold: 1. to provide current information concerning the activities of the NIH by describing in broad terms existing programs offered by NIH; and 2. to solicit through public testimony the views of biomedical researchers, university faculty and administrators, students, representatives of professional societies, and other interested parties regarding the nature and scope of programs to attract and support minorities in biomedical research. The first meeting will be held on Wednesday, March 8, 1989, from 8:30 a.m. to 5:00 p.m. at Jackson State University, Jackson, Mississippi. Subsequent meetings will be held in Bethesda, Maryland (April 20), Atlanta, Georgia (early Summer), Phoenix, Arizona (late Summer), and Anchorage, Alaska (early Fall). Notice of the exact time and location of additional meetings will be published later. Following presentations by senior NIH staff, a panel comprised of NIH program administrators will spend the remainder of the day receiving testimony from public witnesses. Each witness will be limited to a maximum of ten minutes. Attendance and the number of presentations will be limited to the time and space available. Consequently, all individuals wishing to attend or to present a statement at this public meeting should notify, in writing: William H. Pitlick, Ph.D. Executive Secretary National Institutes of Health Shannon Building, Room 250 Bethesda, Maryland 20892 Those planning to make a presentation at Jackson State should file a one-page summary of their remarks with Dr. Pitlick by February 17, 1989; a copy of the full text should be submitted for the record at the time of the meeting. Additional information may be obtained by calling: Ms. Loretta Beuchert Research Training Office Office of Extramural Research National Institutes of Health Shannon Building, Room 250 Bethesda, Maryland 20892 Telephone: (301) 496-9743 EXPANDED AUTHORITIES FOR GRANTEE ORGANIZATIONS -- CLARIFICATION OF APPLICABILITY TO CERTAIN GRANT AWARD MECHANISMS P.T. 34; K.W. 1014002, 1014006 National Institutes of Health INTRODUCTION On October 21, 1988, NIH published a notice (NIH Guide for Grants and Contracts, Vol. 17, No. 34) entitled IMPLEMENTATION OF EXPANDED AUTHORITIES FOR GRANTEE ORGANIZATIONS. That notice described four new policy features that transmit significant additional authority to the recipients of most "R" series grant award mechanisms. Implicitly included among the applicable award mechanisms are the following "special" initiatives: o "R01" The Senator Jacob Javits Neuroscience Investigator Award; o "R29" The First Independent Research Support and Transition (FIRST) Award; o "R35" The Outstanding Investigator Grant (OIG); and o "R37" The Method to Extend Research In Time (MERIT) Award. POLICY CLARIFICATION Since their inception, each of the "special" initiatives cited above has included one or two of the features that are now part of the broadly-based "expanded authorities." The purpose of this notice is to make it explicit that these initiatives are covered by the expanded authorities and, therefore, are to be managed in accordance with the guidance set forth in the NIH notice of October 21, 1988.